Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Capital Expenditures (2021 - 2025)

Historic Capital Expenditures for Neuroone Medical Technologies (NMTC) over the last 5 years, with Q4 2025 value amounting to $40754.0.

  • Neuroone Medical Technologies' Capital Expenditures rose 6691.51% to $40754.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $112682.0, marking a year-over-year increase of 483.8%. This contributed to the annual value of $81742.0 for FY2025, which is 3199.33% down from last year.
  • Neuroone Medical Technologies' Capital Expenditures amounted to $40754.0 in Q4 2025, which was up 6691.51% from $10607.0 recorded in Q3 2025.
  • Neuroone Medical Technologies' Capital Expenditures' 5-year high stood at $175694.0 during Q1 2023, with a 5-year trough of $10607.0 in Q3 2025.
  • Over the past 5 years, Neuroone Medical Technologies' median Capital Expenditures value was $37131.0 (recorded in 2023), while the average stood at $54137.5.
  • Per our database at Business Quant, Neuroone Medical Technologies' Capital Expenditures surged by 22254.17% in 2023 and then tumbled by 8937.4% in 2024.
  • Neuroone Medical Technologies' Capital Expenditures (Quarter) stood at $61491.0 in 2021, then crashed by 81.28% to $11512.0 in 2022, then surged by 222.54% to $37131.0 in 2023, then plummeted by 34.24% to $24416.0 in 2024, then skyrocketed by 66.92% to $40754.0 in 2025.
  • Its last three reported values are $40754.0 in Q4 2025, $10607.0 for Q3 2025, and $24416.0 during Q4 2024.